To delineate the pathologic role of DKK1 in steatosis, first, we found that the hepatic DKK1 expression status was progressively up-regulated as the NAFLD condition advanced in clinical patient and NAFLD mice liver samples and that was confirmed by in vitro fatty acid–induced hepatocyte steatosis. This evidence concerns the gene DKK1 and metabolic dysfunction-associated steatotic liver disease.